Absence of radiographic progression at two years in a cohort of patients with non-radiographic axial spondyloarthritis treated with TNF-α blockers
Reumatol Clin. 2014 Mar-Apr;10(2):134-5.
doi: 10.1016/j.reuma.2013.04.003.
Epub 2013 Jul 1.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Reumatología, Parc de Salut Mar, Barcelona, España. Electronic address: [email protected].
- 2 Servicio de Reumatología, Parc de Salut Mar, Barcelona, España.
No abstract available
MeSH terms
-
Adalimumab
-
Adult
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Cervical Vertebrae / diagnostic imaging*
-
Disease Progression
-
Etanercept
-
Female
-
Follow-Up Studies
-
Humans
-
Immunoglobulin G / therapeutic use
-
Infliximab
-
Lumbar Vertebrae / diagnostic imaging*
-
Male
-
Radiography
-
Receptors, Tumor Necrosis Factor / therapeutic use
-
Sacroiliac Joint / diagnostic imaging*
-
Spondylarthritis / diagnostic imaging
-
Spondylarthritis / drug therapy*
-
Treatment Outcome
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Immunoglobulin G
-
Receptors, Tumor Necrosis Factor
-
Tumor Necrosis Factor-alpha
-
Infliximab
-
Adalimumab
-
Etanercept